TACE Combined With "Target Immune" Therapy for First-line Treatment in the Treatment of Intrahepatic Cholangiocarcinoma
Clinical trial NCT05247996 · UNKNOWN
Trial details
- NCT number
- NCT05247996
- Sponsor
- The Central Hospital of Lishui City
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2022-12-31
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.